Literature DB >> 6494604

Airway function in stage I and stage II pulmonary sarcoidosis.

P K Argyropoulou, D A Patakas, G E Louridas.   

Abstract

Airway function was studied in 39 patients with stage I sarcoidosis and in 20 patients with stage II sarcoidosis. All of our patients were nonsmokers. Characteristic functional changes of restrictive lung disease was observed in 4 patients with stage II sarcoidosis. Specific airway conductance and % FEV1 were abnormal in 3 patients with stage II sarcoidosis. Abnormal small airway function was demonstrated in several patients with stage I and stage II sarcoidosis, always by multiple tests. Frequency dependence of dynamic compliance was demonstrated in 40% of stage I and 50% of stage II sarcoidosis. Maximal flow (Vmax50, Vmax25) was decreased respectively in 36 and 30% of patients of stage I sarcoidosis and in 56 and 62% of patients with stage II sarcoidosis. The ratio of closing volume to vital capacity was increased above corrected predictions in 30% of stage I and 44% of stage II sarcoidosis. delta Vmax25 decreased and Visov/VC (%) increased in more than 50% of patients. Upstream airway resistance was abnormally increased in 50% of patients with stage I and in 73% with stage II sarcoidosis. These results suggest that small airway dysfunction is common in early sarcoidosis without restrictive defect.

Entities:  

Mesh:

Year:  1984        PMID: 6494604     DOI: 10.1159/000194666

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  3 in total

1.  Airway obstruction in sarcoidosis.

Authors:  O P Sharma; T Izumi
Journal:  West J Med       Date:  1988-05

2.  Rare manifestations of sarcoidosis in modern era of new diagnostic tools.

Authors:  Surendra K Sharma; Manish Soneja; Abhishek Sharma; Mehar C Sharma; Smriti Hari
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

3.  Sarcoidosis with Pancreatic Mass, Endobronchial Nodules, and Miliary Opacities in the Lung.

Authors:  Shun Matsuura; Yasutaka Mochizuka; Kyohei Oishi; Koichi Miyashita; Hyogo Naoi; Eisuke Mochizuki; Shinichiro Mikura; Masaru Tsukui; Naoki Koshimizu; Akihiko Ohata; Takahumi Suda
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.